Editas Medicine Inc reports results for the quarter ended in September 30 - Earnings Summary

Editas Medicine

04/11/2024 15:30

* Editas Medicine Inc  EDIT.OQ  reported a quarterly
adjusted loss
of 75 cents​​ per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -55 cents.  The mean expectation of eighteen analysts for
the quarter was for a loss of 75 cents per share. Wall Street
expected results to range from -96 cents to -13 cents per share.
    * Revenue fell 98.9% to $61.00 thousand from a year ago;
analysts
expected $2.24 million. 
    * Editas Medicine Inc's reported EPS for the quarter was a
loss
of 75 cents​.
    * The company reported a quarterly loss of $62.14 million.
    * Editas Medicine Inc shares had fallen by 14.7% this
quarter and
lost 71.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 7.5%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 9
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Editas Medicine
Inc is $10.00 
This summary was machine generated from LSEG data November 4 at
03:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.75          -0.75          Met
 Jun. 30 2024      -0.70          -0.82          Missed
 Mar. 31 2024      -0.66          -0.76          Missed
 Dec. 31 2023      -0.54          -0.23          Beat